ENTRY       D05147                      Drug
NAME        Nesiritide (USAN/INN);
            Natrecor (TN)
FORMULA     C143H244N50O42S4
EXACT_MASS  3461.7377
MOL_WEIGHT  3464.0373
SEQUENCE    Ser Pro Lys Met Val Gln Gly Ser Gly Cys Phe Gly Arg Lys Met Asp
            Arg Ile Ser Ser Ser Ser Gly Leu Gly Cys Lys Val Leu Arg Arg His
            (Disulfide bridge: 10-26)
  TYPE      Peptide
REMARK      ATC code: C01DX19
            Chemical structure group: DG00238
EFFICACY    Vasodilator, Atrial natriuretic peptide receptor agonist
COMMENT     Recombinant of human B-type natriuretic peptide (BNP) [HSA:4879]
            Renin-angiotensin system antagonist
            Treatment of congestive heart failure
TARGET      NPR1 [HSA:4881] [KO:K12323]
  PATHWAY   hsa04270(4881)  Vascular smooth muscle contraction
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C01 CARDIAC THERAPY
               C01D VASODILATORS USED IN CARDIAC DISEASES
                C01DX Other vasodilators used in cardiac diseases
                 C01DX19 Nesiritide
                  D05147  Nesiritide (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Lyases (EC4)
               Phosphorus-oxygen lyases
                NPR1
                 D05147  Nesiritide (USAN/INN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D05147
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D05147
DBLINKS     CAS: 124584-08-3
            PubChem: 47206871
///
